Newsroom

Portrait of Michael Manns
News
The former President of Hannover Medical School (MHH) and Clinical Director of the Helmholtz Centre for Infection Research (HZI), Prof. Michael P. Manns, passed away on 15 August 2025. Manns succumbed to a tumor disease at the age of 73. As a renowned gastroenterologist, he belonged to the worldwide scientific elite, was one of the most cited scientists, and enriched both the German and international research landscape as an excellent communicator. Until the very end, Manns was still actively involved in research at the MHH and promoted the scientific organization of the Centre for Individualised Infection Medicine (CiiM), a joint institution of the HZI and the MHH, which he co-founded. Manns also supported another joint center of the HZI and MHH, the TWINCORE, with his extensive expertise.
18.08.2025
Electron micrograph of Klebsiella oxytoca
News
A balanced gut microbiome not only contributes to digestion, but is also an important protective factor against infections. Researchers at the Helmholtz Centre for Infection Research (HZI) led by Prof. Till Strowig, scientist in the German Center for Infection Research (DZIF), want to harness the power of the microbiome to prevent serious infections. They have discovered that bacteria of the species Klebsiella oxytoca can displace pathogenic bacteria from the gut and want to develop a living biotherapeutic based on this finding. The DZIF is now providing 2.2 million euros in funding for product development until the first tests on humans.
07.08.2025
World map
News
Since the start of the SARS-CoV-2 pandemic, several variants of the virus have developed into Variants of Concern (VOCs), as classified by the World Health Organization (WHO). VOCs are virus variants that are predicted or known to cause large waves of infections due to their altered phenotypic characteristics and with risk of altering disease severity, reducing vaccine effectiveness or otherwise leading to increased burden of health care systems. Researchers at the Helmholtz Centre for Infection Research (HZI) and the German Center for Infection Research (DZIF) have developed an analysis method to detect VOC early in their development. The study was published in the journal Nature Communications.
22.07.2025
Richmond Sarpong with certificate in hand, next to him is Klemens Rottner
News
The Friends of the Helmholtz Centre for Infection Research (HZI) in Braunschweig and the Technische Universität Braunschweig are awarding Prof. Richmond Sarpong from the University of California, Berkeley, with the Inhoffen Medal 2025. Sarpong is an eminent organic chemist who has distinguished himself through particular successes in synthetic chemistry and method development. The award ceremony took place on July 10, 2025 at the HZI in Braunschweig.
11.07.2025
group picture
News
The German Research Foundation (DFG) is funding the DEEP-DV research group for another four years with a total of €5.3 million. This marks the second phase of the successful work of the interdisciplinary group, which includes scientists from Braunschweig, Hamburg, Hannover, Berlin, Regensburg, Ulm, Freiburg, and Munich. DNA viruses such as herpes viruses and polyomaviruses can remain in the body permanently after an initial infection and cause serious health consequences years later.
10.07.2025
Impfstoff
News
A recent study led by the Centre for Individualised Infection Medicine (CiiM) and the Radboud University Medical Center published in Genome Biology shows that BCG vaccination does more than fend off tuberculosis - it leaves enduring chemical marks on immune cells that boost responses to various pathogens. Researchers also uncover hormone‑immune crosstalk and sex‑specific effects that could guide next‑generation, individualised vaccine design.
10.07.2025

HZI in the media

... späten 1990ern hob sie der am Saarbrücker Helmholtz-Institut für Pharmazeutische Forschung Saarland (HIPS) tätige ...

08.03.2026
|
Saarbrücker Zeitung

European institutions, including Germany’s Helmholtz Institute for RNA-based Infection Research, Helmholtz Center for Infection Research,

06.03.2026
|
Clinical Lab Products

Die Zellen kontrollieren die Reaktion des Immunsystems und verhindern Schäden durch Selbstangriffe. Forschende arbeiten daran, sie zur Therapie einzusetzen.

05.03.2026
|
NDR Norddeutscher Rundfunk

Nachwuchsgruppe „Nanoinfektionsbiologie“ am HZI. Diese Lücke soll das Projekt ONEMUC (Respiratorischer Mukus als One Health-Schnittstelle) ...

03.03.2026
|
DeutschesGesundheitsPortal

Hochschule Hannover (MHH) und des Helmholz-Zentrums für Infektionsforschung (HZI) erforschen im Rahmen des Projektes StopPSC ( ...

03.03.2026
|
Biermann Medizin

Mdisk, stock.adobe.com

 

Braunschweig – Das Helmholtz-Zentrum für Infektionsforschung ( HZI ) in Braunschweig erhält für sein ...

03.03.2026
|
Deutsches Ärzteblatt

Josef Penninger, wissenschaftlicher Geschäftsführer des Helmholtz Zentrums für Infektionsforschung in Braunschweig und Professor für

01.03.2026
|
EUROPE SAYS

... Körperzellen. Damit tragen wir, wie das Helmholtz-Zentrum für Infektionsforschung (HZI) es treffend beschreibt, unseren „ganz ...

27.02.2026
|
MSN Deutschland

Eine Impfung bringt das Immunsystem in Stellung, bevor der echte Erreger kommt. Erfahren Sie, wie ...

26.02.2026
|
Apotheken Umschau

Livia V. Patrono, one of the senior authors at the Helmholtz Institute for One Health (HIOH) in Germany, said in a statement .

 

The research

25.02.2026
|
IFL Science

says Livia Patrono, a veterinarian and disease ecologist at Helmholtz Institute for One Health in Greifswald, Germany. In 2012, an infected

24.02.2026
|
Science News

... Dr. rer. nat. Jakob Wirbel vom Helmholtz-Zentrum für Infektionsforschung (Braunschweig). Das Experiment aus Stanford sei ...

20.02.2026
|
Deutsches Ärzteblatt

Register now for the HZI-Newsletter